| Position | Action |
|---|---|
| Initial position reduction | Trim 50-75% of existing long exposure at $308-310 |
| Residual position maintenance | Retain 25-50% residual exposure hedged via wider collar (sell ~$380-400 calls / buy ~$260-270 puts) |
| Avoid initiating below lower Bollinger band | Do not bottom-catch or add new positions below $285.72 |
A 27% drawdown with peak-investment capex distorting near-term FCF, a $27.4B net cash fortress, accelerating revenue (+25.5% YoY), and an intact AI/autonomy pipeline creates an asymmetric risk/reward setup where the market is paying 27% less to own a company planting flags in next decade's growth markets.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | 331.30 | bearish |
| 50 SMA | 392.62 | bearish |
| 200 SMA | 412.22 | bearish |
| RSI(14) | 30.56 | neutral |
| Bollinger Middle (20 SMA) | 368.04 | bearish |
| Bollinger Lower Band | 285.72 | bearish |
| MACD Line | -25.53 | bearish |
| MACD Signal Line | -17.06 | bearish |
| MACD Histogram | -8.47 | bearish |
| 30-day VWMA | 344.57 | bearish |
| Close (Jul 30) |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Trim 50-75% of TSLA longs immediately at $308-310; retain hedged residual via wider collar to participate in tail upside
Path of least resistance is toward $260-285. Underweight rating acknowledges dominant bear evidence (FCF turned negative, operating income collapsed 58% sequentially, gross margin compressed to 16.8%, 139x forward P/E unjustified) while hedged residual preserves upside participation if macro pivots or Q3 catalyst surprises. Risk to thesis: Fed pivot or Q3 FCF recovery. Avoid falling-knife zone below $285.72.
When: Daily close above 200 SMA ($412.22) with VWMA turning up
Then: Full reload of position
Tesla is an AI/robotics platform, not an auto manufacturer, and the current valuation reflects future earnings from its autonomy and robotics pipeline
↩ rebuts: “Bear fair value estimate of $250 applying 'Toyota math' to Tesla”
· concedes: The bear correctly identifies legs one and two of the capitulation pattern; Margin compression to 16.8% is real; RSI at 25.42 is not a guarantee of immediate reversal; Wait for close above 10 EMA at $331.30 on expanding volume for confirmation; Appropriate position sizing is needed given volatility; Technical invalidation below $285 should be respected; The bull case doesn't need the bear to be wrong on every point—just needs the FCF-negative-quarter to be what it actually is: a peak investment quarter, not a deteriorating business
Tesla trades at 139x forward P/E while fundamentals deteriorate (negative FCF, margin compression, YoY earnings decline), requiring flawless six-variable execution across AI/robotics/macro to justify the valuation — any single failure breaks the thesis, making the path of least resistance lower.
· concedes: Energy storage growth is genuinely bullish but insufficient to carry the thesis alone; Tesla's data moat in consumer autonomy is real; RSI at 30.56 does indicate some oversold condition; Prior 30%+ drawdowns have historically delivered positive returns 3-6 months later in many cases
→ vs neutral: FCF swung $5 billion in nine months; calling 139x forward P/E 'priced in' is mathematically illiterate
→ vs neutral: HOLD recommendation fails to act on deteriorating fundamentals; waiting through margin compression is not a strategy
→ vs conservative: No basing pattern exists—RSI at 30 with no divergence, MACD making new lows, 10 EMA collapsing daily; 'wait for base' is hope dressed as analysis
→ vs conservative: 19% dilution in nine months and $4.6B annualized SBC transfers ~1.5% of market cap annually from shareholders to employees; 'hold through dilution' is philanthropy, not investing
→ vs conservative: Modest 25-50% trim leaves catastrophic exposure at 139x forward earnings with broken margins and hostile macro
| 308.85 |
| neutral |
| Jul 23 Volume Spike | 115.6M shares | bearish |
Support: 285.72 · 297.38 | Resistance: 331.3 · 368.04 · 392.62 · 412.22
Bear-stack confirmed: price below all three moving averages (10 EMA, 50 SMA, 200 SMA) with no golden/death cross forming as all averages slope down together. MACD histogram making new lows each session (trend: -1.13 → -1.35 → -2.14 → -6.86 → -8.47 on Jul 22-30), indicating no momentum exhaustion. Bollinger lower band continues rising (304.56 → 292.71 → 285.72 from Jul 28-30) during ongoing band-walk lower—a late-stage capitulation pattern, but true mean-reversion requires band contraction (squeeze), not yet observed. Volume-weighted trend confirms no buying pressure: VWMA declining from 403.80 (Jul 17) to 344.57, with Jul 23 capitulation bar (115.6M shares) followed by moderate volume (36.6M-44.9M) but no high-volume reversal day—the third leg of selling exhaustion pattern absent. The 10 EMA collapsing daily (336.29 → 331.30 over two days) means short-term trend still deteriorating. Actionable triggers: below $285.72 targets $260-270; reclaiming $331.30 on two consecutive closes with rising volume and contracting MACD histogram would signal first tactical long entry.
Market Cap
$1.220 trillion
P/E Ratio (TTM)
288.6x
Forward P/E
139.3x
Price / Book
13.79x
52-Week High
$498.83
52-Week Low
$297.38
50-Day Moving Avg
$394.64
200-Day Moving Avg
$412.75
Book Value per Share
$22.40
Q2 2026 Revenue
$28.24B
Q2 2026 Gross Profit
$4.75B
Q2 2026 Gross Margin
16.8%
Q2 2026 Operating Income
$398M
Q2 2026 Net Income
$1,114M
Q2 2026 Diluted EPS
$0.32
Q1 2026 Revenue
$22.39B
Q1 2026 Gross Profit
$4.72B
Q1 2026 Gross Margin
21.1%
Q1 2026 Operating Income
$941M
Q1 2026 Net Income
$477M
Q1 2026 Diluted EPS
$0.13
Q4 2025 Revenue
$24.90B
Q4 2025 Gross Profit
$5.01B
Q4 2025 Gross Margin
20.1%
Q4 2025 Operating Income
$1,409M
Q4 2025 Net Income
$840M
Q4 2025 Diluted EPS
$0.24
Q3 2025 Revenue
$28.10B
Q3 2025 Gross Profit
$5.05B
Q3 2025 Gross Margin
18.0%
Q3 2025 Operating Income
$1,624M
Q3 2025 Net Income
$1,373M
Q3 2025 Diluted EPS
$0.39
Q2 2025 Revenue
$22.50B
Q2 2025 Gross Profit
$3.88B
Q2 2025 Gross Margin
17.2%
Q2 2025 Operating Income
$923M
Q2 2025 Net Income
$1,172M
Q2 2025 Diluted EPS
$0.33
Q2 2026 R&D Spend
$2.37B
Q2 2025 R&D Spend
$1.59B
R&D Spend YoY Change
+49%
Q2 2026 SG&A
$1.98B
Q2 2025 SG&A
$1.37B
SG&A YoY Change
+45%
Q2 2026 Net Interest Income
$341M
Total Assets (Q2 2026)
$148.5B
Total Assets (Q1 2026)
$143.7B
Total Assets (Q4 2025)
$137.8B
Total Assets YoY Change
+15.5%
Total Equity (Q2 2026)
$86.9B
Total Equity (Q1 2026)
$84.1B
Total Equity (Q4 2025)
$82.1B
Total Equity YoY Change
+12.4%
Total Debt (Q2 2026)
$16.1B
Total Debt (Q1 2026)
$15.9B
Total Debt (Q4 2025)
$14.7B
Total Debt YoY Change
+22.5%
Cash & ST Investments (Q2 2026)
$43.5B
Cash & ST Investments (Q1 2026)
$44.7B
Cash & ST Investments (Q4 2025)
$44.1B
Cash & ST Investments YoY Change
+18.3%
Net Cash Position (Q2 2026)
~$27.4B
Net Cash Position (Q1 2026)
~$28.8B
Net Cash Position (Q4 2025)
~$29.4B
Inventory (Q2 2026)
$13.8B
Inventory (Q1 2026)
$14.4B
Inventory (Q4 2025)
$12.4B
Inventory YoY Change
-5.5%
Net PP&E (Q2 2026)
$62.4B
Net PP&E (Q1 2026)
$58.6B
Net PP&E (Q4 2025)
$56.2B
Net PP&E YoY Change
+15.1%
Working Capital (Q2 2026)
$33.3B
Working Capital (Q1 2026)
$35.6B
Working Capital (Q4 2025)
$36.9B
Working Capital YoY Change
+7.1%
Debt-to-Equity
~0.18x
Current Ratio
~1.9x
Q2 2026 Operating Cash Flow
$4.70B
Q2 2026 CapEx
$5.80B
Q2 2026 Free Cash Flow
-$1.10B
Q2 2026 Financing CF
$0.04B
Q1 2026 Operating Cash Flow
$3.94B
Q1 2026 CapEx
$2.49B
Q1 2026 Free Cash Flow
$1.44B
Q1 2026 Financing CF
$1.17B
Q4 2025 Operating Cash Flow
$3.81B
Q4 2025 CapEx
$2.39B
Q4 2025 Free Cash Flow
$1.42B
Q4 2025 Financing CF
$0.71B
Q3 2025 Operating Cash Flow
$6.24B
Q3 2025 CapEx
$2.25B
Q3 2025 Free Cash Flow
$3.99B
Q3 2025 Financing CF
$0.98B
Q2 2025 Operating Cash Flow
$2.54B
Q2 2025 CapEx
$2.39B
Q2 2025 Free Cash Flow
$0.15B
Q2 2025 Financing CF
-$0.22B
Q2 2026 SBC
$1.15B
SBC Annualized (estimated)
~$5.5B
Shares Outstanding (Q3 2025)
3.324B
Shares Outstanding (Q2 2026)
3.949B
Share Count Increase
~19%
Diluted Shares
3.54B
Q2 2026 New Debt Issued
$348M
Q2 2026 Debt Repayments
$411M
EBIT Margin (Q2 2026)
~5%
EBIT Margin (Q1 2026)
~10%
Operating Margin (Q2 2026)
1.4% (rep.)
Net Margin (Q2 2026)
3.9%
Typical CapEx Run Rate
~$2.4B
Strengths
Concerns
Tesla's Q2 2026 earnings reveal a mixed fundamental picture: revenue hit a record $28.24B (+25.5% YoY) driven by volume growth, but profitability metrics deteriorated sharply with gross margin compressing 430bps sequentially to 16.8% and operating income collapsing 58% to $398M, suggesting margin pressure from pricing actions, mix shifts, or ramp costs on new products. The balance sheet remains fortress-like with $27.4B net cash and 0.18x debt-to-equity, but cash flow turned negative (-$1.10B FCF) as capex spiked 2.4x to $5.80B for AI compute, Optimus production lines, and new vehicle platform investments; combined with ~19% share dilution in 9 months from stock-based compensation, per-share metrics face structural headwinds. The stock's extreme valuation (288.6x trailing P/E, 139.3x forward P/E) prices in substantial AI/robotics optionality from FSD, robotaxi, and Optimus commercialization, making it essentially a call option that requires flawless execution to justify current multiples.